jpg", "id": "F5", "section_type": "FIG", "type": "fig_caption"}, "text": "(G) RXRalpha/Delta80 promotes clonogenic survival of cancer cells grown in 6-well plates for 8 days.", "sentences": [], "annotations": [], "relations": []}, {"offset": 43897, "infons": {"file": "nihms203815f5.jpg", "id": "F5", "section_type": "FIG", "type": "fig_caption"}, "text": "(H,I) RXRalpha/Delta80 promotes cancer cell growth in nude mice (n=6) for three weeks. One of three to five similar experiments is shown. Error bars represent SEM.", "sentences": [], "annotations": [], "relations": []}, {"offset": 44061, "infons": {"file": "nihms203815f5.jpg", "id": "F5", "section_type": "FIG", "type": "fig_caption"}, "text": "See also Figure S5.", "sentences": [], "annotations": [], "relations": []}, {"offset": 44081, "infons": {"file": "nihms203815f6.jpg", "id": "F6", "section_type": "FIG", "type": "fig_title_caption"}, "text": "Activation of TNFalpha-induced Extrinsic Apoptotic Pathway by Sulindac", "sentences": [], "annotations": [], "relations": []}, {"offset": 44152, "infons": {"file": "nihms203815f6.jpg", "id": "F6", "section_type": "FIG", "type": "fig_caption"}, "text": "(A) Synergistic induction of apoptosis by Sulindac/TNFalpha combination and its inhibition by RXRalpha ligand. HepG2 cells cultured in medium with 1% FBS were treated with SR11237 (1 muM) for 1 hr, then TNFalpha (10 ng/ml) and/or Sulindac (75 muM) for 4 hr, and analyzed by immunoblotting.", "sentences": [], "annotations": [], "relations": []}, {"offset": 44442, "infons": {"file": "nihms203815f6.jpg", "id": "F6", "section_type": "FIG", "type": "fig_caption"}, "text": "(B) Inhibition of Sulindac/TNFalpha-induced caspases-8 cleavage by RXRalpha siRNA. HepG2 cells transfected with control or RXRalpha siRNA were treated with TNFalpha and/or Sulindac and analyzed by immunoblotting.", "sentences": [], "annotations": [], "relations": []}, {"offset": 44655, "infons": {"file": "nihms203815f6.jpg", "id": "F6", "section_type": "FIG", "type": "fig_caption"}, "text": "(C,D) Inhibition of Sulindac/TNFalpha-induced PARP cleavage by caspase-8 inhibitor and siRNA. HepG2 cells transfected with control or caspase-8 siRNA or pretreated with Z-IETD-fmk (40 muM) for 1 hr were treated with TNFalpha and Sulindac and analyzed by immunoblotting.", "sentences": [], "annotations": [], "relations": []}, {"offset": 44925, "infons": {"file": "nihms203815f6.jpg", "id": "F6", "section_type": "FIG", "type": "fig_caption"}, "text": "(E) Activation of Bax by Sulindac and TNFalpha. HepG2 cells treated with TNFalpha and/or Sulindac were immunostained with Bax/6A7 antibody. About 15% Sulindac-treated cells while about 60% Sulindac/TNFalpha-treated cells showed Bax staining.", "sentences": [], "annotations": [], "relations": []}, {"offset": 45167, "infons": {"file": "nihms203815f6.jpg", "id": "F6", "section_type": "FIG", "type": "fig_caption"}, "text": "(F) Regulation of Sulindac/TNFalpha-induced PARP cleavage by AKT. PC3 cells transfected with CA-AKT or DN-AKT were treated with TNFalpha and/or Sulindac, and analyzed by immunoblotting.", "sentences": [], "annotations": [], "relations": []}, {"offset": 45353, "infons": {"file": "nihms203815f6.jpg", "id": "F6", "section_type": "FIG", "type": "fig_caption"}, "text": "(G,H) CA-AKT inhibits activation of caspase-8 (G) and Bax (H) by Sulindac and TNFalpha. HepG2 cells transfected with CA-AKT were treated with TNFalpha and Sulindac, and immunostained with anti-cleaved caspase-8 or Bax/6A7 antibody. About 80% nontransfected and 15% CA-AKT-transfected cells showed caspase-8 staining. About 60% nontransfected and about 13% CA-AKT-transfected cells exhibited Bax staining.", "sentences": [], "annotations": [], "relations": []}, {"offset": 45758, "infons": {"file": "nihms203815f6.jpg", "id": "F6", "section_type": "FIG", "type": "fig_caption"}, "text": "(I) Regulation of c-FLIP expression by TNFalpha and Sulindac. Cells treated with TNFalpha and/or Sulindac for 6 hr were analyzed by immunoblotting.", "sentences": [], "annotations": [], "relations": []}, {"offset": 45906, "infons": {"file": "nihms203815f6.jpg", "id": "F6", "section_type": "FIG", "type": "fig_caption"}, "text": "One of three to five similar experiments is shown.", "sentences": [], "annotations": [], "relations": []}, {"offset": 45957, "infons": {"file": "nihms203815f6.jpg", "id": "F6", "section_type": "FIG", "type": "fig_caption"}, "text": "See also Figure S6.", "sentences": [], "annotations": [], "relations": []}, {"offset": 45977, "infons": {"file": "nihms203815f7.jpg", "id": "F7", "section_type": "FIG", "type": "fig_title_caption"}, "text": "Design, Synthesis and Evaluation of RXRalpha-selective Sulindac Analogs", "sentences": [], "annotations": [], "relations": []}, {"offset": 46049, "infons": {"file": "nihms203815f7.